These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 2449815)

  • 1. Reduction in infarct size by the prostacyclin analogue iloprost (ZK 36374) after experimental coronary artery occlusion-reperfusion.
    Chiariello M; Golino P; Cappelli-Bigazzi M; Ambrosio G; Tritto I; Salvatore M
    Am Heart J; 1988 Mar; 115(3):499-504. PubMed ID: 2449815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and late administration of a PGI2-analogue, ZK 36 374 (iloprost): effects on myocardial preservation, collateral blood flow and infarct size.
    Smith EF; Gallenkämper W; Beckmann R; Thomsen T; Mannesmann G; Schrör K
    Cardiovasc Res; 1984 Mar; 18(3):163-73. PubMed ID: 6200229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iloprost inhibits neutrophil function in vitro and in vivo and limits experimental infarct size in canine heart.
    Simpson PJ; Mickelson J; Fantone JC; Gallagher KP; Lucchesi BR
    Circ Res; 1987 May; 60(5):666-73. PubMed ID: 2439229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a time window for therapy to reduce experimental canine myocardial injury: suppression of neutrophil activation during 72 hours of reperfusion.
    Simpson PJ; Fantone JC; Mickelson JK; Gallagher KP; Lucchesi BR
    Circ Res; 1988 Dec; 63(6):1070-9. PubMed ID: 2461814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oral pretreatment with metoprolol on left ventricular wall motion, infarct size, hemodynamics, and regional myocardial blood flow in anesthetized dogs during thrombotic coronary artery occlusion and reperfusion.
    Zmudka K; Dubiel J; Vanhaecke J; Flameng W; De Geest H
    Cardiovasc Drugs Ther; 1994 Jun; 8(3):479-87. PubMed ID: 7947365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of PGI2 analog iloprost on myocardial infarct size, regional myocardial blood flow, and platelet function in rabbits with coronary artery occlusion followed by reperfusion.
    Golino P; Cappelli-Bigazzi M; Perrone-Filardi P; Nevola E; Quattrin S; Salvatore M; Chiariello M
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():377-80. PubMed ID: 2444078
    [No Abstract]   [Full Text] [Related]  

  • 7. Beneficial effects of iloprost in the stunned canine myocardium.
    Farber NE; Pieper GM; Thomas JP; Gross GJ
    Circ Res; 1988 Feb; 62(2):204-15. PubMed ID: 2448057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iloprost (ZK 36374) enhances recovery of regional myocardial function during reperfusion after coronary artery occlusion in the pig.
    van der Giessen WJ; Schoutsen B; Tijssen JG; Verdouw PD
    Br J Pharmacol; 1986 Jan; 87(1):23-7. PubMed ID: 2420399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitation of myocardial unperfused area and necrotic zone 24 hours and 7 days after coronary artery ligation in rats by the stable prostacyclin analogue iloprost.
    Mueller B; Maass B; Krause W; Witt W
    Prostaglandins Leukot Med; 1986 Mar; 21(3):331-40. PubMed ID: 2422667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs.
    Yao Z; Gross GJ
    Circulation; 1994 Apr; 89(4):1769-75. PubMed ID: 8149542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the stable prostacyclin analogue ZK 36374 on experimental coronary thrombosis in the pig.
    van der Giessen WJ; Mooi WJ; Rutteman AM; Berk L; Verdouw PD
    Thromb Res; 1984 Oct; 36(1):45-51. PubMed ID: 6209820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs.
    Mizumura T; Nithipatikom K; Gross GJ
    Circulation; 1995 Sep; 92(5):1236-45. PubMed ID: 7648671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reduction of myocardial occlusion-reperfusion necrosis by the administration of a stable prostacyclin analog in the rabbit].
    Golino P; Tritto I; Vallone C; Prota S; Salvatore M; Chiariello M
    Cardiologia; 1988 Apr; 33(4):381-4. PubMed ID: 2457441
    [No Abstract]   [Full Text] [Related]  

  • 14. Does preconditioning protect the coronary vasculature from subsequent ischemia/reperfusion injury?
    Bauer B; Simkhovich BZ; Kloner RA; Przyklenk K
    Circulation; 1993 Aug; 88(2):659-72. PubMed ID: 8339428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial temperature reduction attenuates necrosis after prolonged ischemia in rabbits.
    Hale SL; Kloner RA
    Cardiovasc Res; 1998 Dec; 40(3):502-7. PubMed ID: 10070490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ortho-iodo sodium benzoate on acute myocardial ischemia, hemodynamic function, and infarct size after coronary artery occlusion in dogs.
    Rude RE; Tumas J; Gunst M; Kloner RA; DeBoer LW; Maroko PR
    Am J Cardiol; 1983 May; 51(8):1422-7. PubMed ID: 6846170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of two perfluorocarbon emulsions on reperfusion injury after coronary artery occlusion in rabbits.
    Hale SL; Hammerman H; Kloner RA
    Basic Res Cardiol; 1995; 90(5):404-9. PubMed ID: 8585862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central haemodynamic and antiplatelet effects of iloprost--a new prostacyclin analogue--in acute myocardial infarction in man.
    Swedberg K; Held P; Wadenvik H; Kutti J
    Eur Heart J; 1987 Apr; 8(4):362-8. PubMed ID: 2440682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostacyclin analogue iloprost decreases thrombolytic potential of tissue-type plasminogen activator in canine coronary thrombosis.
    Nicolini FA; Mehta JL; Nichols WW; Saldeen TG; Grant M
    Circulation; 1990 Mar; 81(3):1115-22. PubMed ID: 1689620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of the deleterious effects of platelets activated during cardiopulmonary bypass. Comparison of a thromboxane synthetase inhibitor and a prostacyclin analogue.
    Huddleston CB; Hammon JW; Wareing TH; Lupinetti FM; Clanton JA; Collins JC; Bender HW
    J Thorac Cardiovasc Surg; 1985 Feb; 89(2):190-5. PubMed ID: 2578591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.